• Dutasteride in Prostate Cancer Research: Mechanisms and Adva

  2026-05-15

  Explore the dual 5-alpha-reductase inhibitor Dutasteride and its advanced applications in prostate cancer and BPH research. This article offers a uniquely technical perspective on apoptosis induction and assay optimization, distinct from standard reviews.

• Methotrexate: Folate Antagonist Mechanisms & Research Protoc

  2026-05-15

  Methotrexate is a well-characterized folate antagonist that inhibits dihydrofolate reductase (DHFR) and modulates DNA synthesis. It is widely employed as an immunosuppressive and anti-inflammatory agent in preclinical research, with robust evidence supporting its use for apoptosis induction in activated T cells and adenosine-mediated anti-inflammatory mechanisms.

• FXR-KLF11 Axis: CDCA Suppresses JAK2/STAT3 in CI-AKI Models

  2026-05-14

  This study reveals that Chenodeoxycholic Acid (CDCA) mitigates contrast-induced acute kidney injury (CI-AKI) by activating FXR, which transcriptionally upregulates KLF11 and suppresses the pro-inflammatory JAK2/STAT3 pathway. The findings clarify a mechanistic pathway for renal protection and inform future research into prophylactic strategies targeting nuclear receptor signaling.

• Merbromin as a Selective Mixed-Type Inhibitor of SARS-CoV-2

  2026-05-14

  This study identifies Merbromin as a potent, selective mixed-type inhibitor of the SARS-CoV-2 main protease (3CLpro) through high-throughput screening of ~6,000 compounds. The results have significant implications for antiviral drug development and highlight the specificity of Merbromin in distinguishing viral proteases from common laboratory proteases such as Proteinase K.

• CD147+ Small Extracellular Vesicles Drive HCC Angiogenesis v

  2026-05-13

  Huang et al. (2023) identify CD147-positive small extracellular vesicles (sEVs) from hepatocellular carcinoma (HCC) cells as a potential diagnostic biomarker and mechanistic driver of angiogenesis. The study demonstrates that these sEVs activate the PI3K/Akt pathway in endothelial cells, promoting angiogenesis and suggesting new avenues for noninvasive diagnosis and targeted intervention.

• ICG001: Wnt/β-Catenin Pathway Inhibitor for Fibrosis Researc

  2026-05-13

  ICG001 enables precise dissection of Wnt/β-catenin signaling in fibrosis and cancer models, with robust protocol guidance rooted in recent mechanistic advances. Leverage its selectivity and reproducibility for challenging EMT-driven disease workflows, with actionable troubleshooting to maximize data quality.

• Perospirone Inhibits Kv1.5 Channels: Cardiovascular Insights

  2026-05-12

  This study demonstrates that Perospirone (SM-9018 free base), beyond its established role in serotonergic and dopaminergic modulation for schizophrenia, also exhibits direct, concentration-dependent inhibition of vascular Kv1.5 channels. These findings highlight an off-target action with potential implications for both neuropsychiatric and cardiovascular research models.

• JAK2/STAT1 Pathway in Diuron-Induced Acute Renal Injury: Mec

  2026-05-12

  This study integrates network toxicology, transcriptomics, and in vitro validation to elucidate how Diuron activates the JAK2/STAT1 pathway, leading to acute kidney injury. The findings refine mechanistic understanding of Diuron’s nephrotoxicity and support improved risk assessment in environmental toxicology.

• Targeted mRNA Delivery to Islet β Cells via Lipid Nanopartic

  2026-05-11

  Enriquez et al. developed a conjugated lipid nanoparticle (LNP) system for selective mRNA delivery to pancreatic islet β cells, addressing a critical challenge in type 1 diabetes (T1D) therapy. Their work demonstrates functional mRNA delivery in both mouse and human β cells and shows that PD-L1 mRNA expression can modulate immune responses and delay diabetes onset in vivo.

• Merbromin Selectively Inhibits SARS-CoV-2 3CLpro: Implicatio

  2026-05-11

  This study identifies merbromin as a potent, selective mixed-type inhibitor of the SARS-CoV-2 main protease (3CLpro), with negligible activity against common broad-spectrum serine proteases such as Proteinase K. The findings clarify merbromin's inhibitory mechanism and underscore the importance of assay specificity in antiviral drug discovery.

• PBS Liposomes: Mechanistic Insights and Future Innovations

  2026-05-10

  Explore the scientific foundations of PBS Liposomes as a phosphate-buffered saline liposome control for macrophage depletion studies. This article delves into their mechanistic action, storage stability, and the broader implications of recent TRPM3 research for experimental design.

• Applied HOBt (1-Hydroxybenzotriazole) in Peptide Synthesis

  2026-05-09

  Unlock high-fidelity peptide and amide bond formation with HOBt—minimizing epimerization and enabling synthesis of complex bioactive molecules. This guide translates cutting-edge research into actionable workflows, comparative advantages, and troubleshooting strategies for maximizing your results with APExBIO’s high-purity HOBt.

• Proteinase K: Strategic Leverage for DNA Integrity in Transl

  2026-05-09

  This article provides a mechanistic and strategic roadmap for translational researchers aiming to optimize DNA isolation workflows. By dissecting the biochemical underpinnings of Proteinase K and contrasting its utility against alternative proteases, we deliver actionable guidance aligned with the demands of high-fidelity genomics. Drawing on recent reference studies and real-world protocol data, we clarify how Proteinase K, as produced by APExBIO, uniquely addresses the dual imperatives of contaminant removal and DNA integrity preservation in complex biological samples.

• FGF Signaling Drives Non-Cell Autonomous Apoptosis Resistanc

  2026-05-08

  This study uncovers how apoptotic stress can trigger fibroblast growth factor (FGF) signaling, leading to increased expression of anti-apoptotic BCL-2 proteins in neighboring cells. The findings reveal a novel, non-cell autonomous resistance mechanism to apoptosis, with implications for therapeutic strategies targeting BCL-2 in cancer and tissue repair contexts.

• Sulfo-NHS-Biotin: Water-Soluble Protein Labeling Reagent Ins

  2026-05-07

  Sulfo-NHS-Biotin is a highly water-soluble, amine-reactive biotinylation reagent optimized for selective cell surface protein labeling. Its membrane-impermeant chemistry enables precise, irreversible conjugation to accessible primary amines, supporting robust workflows in affinity chromatography and immunoprecipitation. This article details its mechanism, evidence, and limitations for advanced protein analysis.

8212 records 12/548 page Previous Next First page 上5页 1112131415 下5页 Last page